Image of hexagons overlapping in different sizes

Subcutaneous Biologics: Advancing High-Concentration Technologies and Justifying CQA Specification Limits Through Translational Immunogenicity Models – Status Update

Home / Papers and Presentations / Resource
Image with text 'cmc strategy forum europe'

Speaker Presentation: CMC Strategy Forum Europe 2025
Bechtold-Peters Karoline, Novartis Pharma AG, 2025
Subcutaneous Biologics: Advancing High-Concentration Technologies and Justifying CQA Specification Limits Through Translational Immunogenicity Models – Status Update

Related Files